MacroGenics
MGNX
#8416
Rank
NZ$0.47 B
Marketcap
NZ$7.52
Share price
-3.52%
Change (1 day)
207.14%
Change (1 year)

MacroGenics (MGNX) - Net assets

Net assets on the balance sheet as of March 2026 : NZ$36.41 Million

According to MacroGenics's latest financial reports the company has NZ$36.41 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MacroGenics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$NZ$95.98 M-53.36%
2024-12-31$NZ$0.20 B-14.73%
2023-12-31$NZ$0.24 B7.89%
2022-12-31$NZ$0.22 B-36.24%
2021-12-31$NZ$0.35 B-14.45%
2020-12-31$NZ$0.41 B19.75%
2019-12-31$NZ$0.34 B-5.42%
2018-12-31$NZ$0.36 B-14.06%
2017-12-31$NZ$0.42 B8.6%
2016-12-31$NZ$0.38 B-15.25%
2015-12-31$NZ$0.45 B195.75%
2014-12-31$NZ$0.15 B61.2%
2013-12-31$NZ$96.03 M-1059.03%
2012-12-31$-NZ$10.02 Million-55.3%
2011-12-31$-NZ$22.41 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
NZ$155.31 B 426,374.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.59 B 147,074.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.78 B 43,253.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$40.25 B 110,434.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$78.90 B 216,576.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$34.53 B 94,729.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$0.88 B 2,332.46%๐Ÿ‡บ๐Ÿ‡ธ USA